Perspectum
nash drug approvals expected to drive adoption nash therapeutics in development estimated to cost up to year of therapy | Perspectum
Company
Deck Type
IPO
Deck date
July 2021
Slide
19 of 78
Related slides by other companies
Absci
Investor Presentation
October 2023
the drug discovery paradigm is ripe for disruption a | Absci
Absci
Investor Presentation
October 2023
what if the next transformative drug was not discovered but created with a click of a button | Absci
argenx SE
Results
May 2021
first in class antagonist patients on drug for more than years | argenx SE
argenx SE
Results
March 2021
first in class antagonist patients on drug for more than years | argenx SE
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io